U.S. markets open in 6 hours 46 minutes

Novo Nordisk A/S (NVO)

NYSE - NYSE Delayed Price. Currency in USD
100.92+0.52 (+0.52%)
At close: 04:00PM EST
100.66 -0.26 (-0.26%)
After hours: 07:57PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close100.40
Bid0.00 x 800
Ask0.00 x 1000
Day's Range99.58 - 101.14
52 Week Range62.41 - 105.69
Avg. Volume4,847,479
Market Cap458.636B
Beta (5Y Monthly)0.19
PE Ratio (TTM)41.36
Earnings DateN/A
Forward Dividend & Yield1.03 (1.02%)
Ex-Dividend DateAug 18, 2023
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-22% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for NVO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Novo Nordisk A/S
    Weekly Stock ListGlobal stocks are picking up the pace. While the S&P 500 has jumped almost 11% in the past month, the EAFA index of large- and mid-cap stocks based in countries other than the U.S. and Canada has risen 10%. Over the past six years, the performance gap has been wider, with the S&P 500 advancing 12% compared to a 7% gain for the EAFE. But the underperformance has given global stocks a valuation advantage, particularly in the area of dividends. The EAFE dividend yield of 2.4% is 80 basis points higher than the comparable S&P 500 dividend yield. We think global dividend stocks now offer opportunity, particularly given the endless speculation over the direction of interest rates in the U.S., which has created market-timing headaches for equity income investors. Those investors have endured recent wide swings in prices for rate-sensitive equity sectors such as Utilities, REITs and MLPs. In our view, investing in international income stocks is one way to increase portfolio diversification while reducing sensitivity to volatile U.S interest rates. Investing in overseas stocks carries its own set of risks, including the impact of currency exchange and geopolitical turmoil. But there are also a number of positives in this asset class for U.S. investors, including a wide selection of companies that pay dividends, robust industry diversification, and, as we have mentioned, higher yields and lower valuations. Argus has recently boosted its global coverage, and recommends the following international dividend stocks, each of which has at least a long-term HOLD rating from an Argus analyst.
    Fair Value
    Economic Moat
    19 hours agoArgus Research
View more
  • Financial Times

    Novo Nordisk seeks to use obesity drug findings to prevent weight gain

    Obese and overweight patients clamouring for Novo Nordisk’s weight-loss and diabetes drugs have helped the Danish drugmaker grow into Europe’s largest company. Now, it wants to go a step further and stop people gaining weight in the first place. Novo Nordisk chief executive Lars Fruergaard Jørgensen has set his eyes on another “gold mine”: trial data that could offer clues on why some people are more likely to gain weight, and perhaps even lead to the first drugs designed to prevent obesity.

  • Investopedia

    8 Forces That Shaped 2023—in Charts

    From the boom in big tech stocks fueled by enthusiasm for developments in AI to historic strikes by workers for better wages, we take a look back at just a few of the forces that shaped 2023, in charts.

  • Zacks

    Centene (CNC) Wins Contract From Arizona's Medicaid Agency

    Centene's (CNC) Arizona subsidiary has been chosen by the AHCCCS to improve health outcomes for the state's ALTCS-E/PD members and further solidify statewide presence.